PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED

Clinical trials for PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED explained in plain language.

Never miss a new study

Get alerted when new PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED trials appear

Sign up with your email to follow new studies for PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New IV drug trial offers hope for patients with aggressive lymphoma

Disease control Recruiting now

This is an early-stage study testing a new intravenous drug called ST-001 for people with T-cell lymphoma that has come back or not responded to prior treatments. The main goals are to find the highest safe dose and understand how the drug works in the body. It is for adults whos…

Matched conditions: PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED

Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED

Get alerted when new PERIPHERAL T-CELL LYMPHOMA, NOT CLASSIFIED trials appear

New IV drug trial offers hope for patients with aggressive lymphoma